PHENOLIC CONSTITUENTS FROM SARCOPYRAMIS NEPALENSIS AND THEIR A-GLUCOSIDASE INHIBITORY ACTIVITY|
Tan, Chao; Zuo, Jiangcheng; Yi, Xiaofang; Wang, Peng; Luo, Chunhua; Hu, Yong; Yi, Hong & Qiao, Wei
Background: This study was carried out to fully investigate the phenolic chemical constituents of Sarcopyramis nepalensis and determine their
α-glucosidase inhibitory activity.
Materials and Methods: S. nepalensis was extracted using the ultrasonic assistant extraction (UAE) method and further fractionated with
petroleum ether (PE), chloroform (CHCl3), ethyl acetate (EtOAc) and n-butanol (n-BuOH), respectively. The active fraction was
chromatographed on AB-8 macroporous resin column, silica gel column, Sephadex LH-20 column, RP-ODS column and semi-preparative HPLC
column. The isolated phenolic constituents were identified by 1H-Nuclear Magnetic Resonance (NMR), 13C-NMR and mass spectral (MS)
analyses and detected their α-glucosidase inhibitory activity by micro-plate.
Results: Ten phenolic constituents were isolated and identified from the active fraction of S. nepalensis. They were identified as isorhamnetin(1),
quercetin(2), isorhamnetin-3-O-β-D-glucopyranoside(3), isoquercetin (4),
acid(8) Caffeic acid(9) and ellagic acid(10). All of the phenolic compounds were assayed for their hypoglycemic activity against α-glucosidase in
vitro. Compound 4, 6 and 7 showed promising α-glucosidase inhibitory activity with the IC50 values of 0.69 mg/ml, 0.56 mg/ml, 0.45 mg/ml,
Conclusion: Compounds 5-8 were isolated for the first time from S. nepalensis. This is the first report on the characterization of phenolic
compounds and possible utilization of S. nepalensis for therapeutic intervention in type 2 diabetes.
α-glucosidase inhibitory; Phenolic constituents; Sarcopyramis nepalensis